Offseason acquisition unlikely to make Pistons debut until 2024

Monte Morris' debut for the Pistons is unlikely to happen until 2024. The team announced in a press release that Morris, who continues to rehab a right quad strain, underwent a PRP (platelet rich plasma) injection last Friday and is expected to be reevaluated in about six to eight weeks.

Detroit acquired Morris from the Wizards in a July trade in exchange for a future second-round pick. The plan was for him to be a steady presence in a young backcourt that features recent first-rounders like Cade Cunningham, Jaden Ivey, Killian Hayes, and Marcus Sasser.

However, Morris was affected during the preseason by lower back soreness, then hurt his quad while rehabbing his back injury. He has yet to play this season, and even if he can return in just six weeks, that would mean he’d be sidelined until early January.

Morris, a Michigan native, averaged 10.3 points, 5.3 assists, and 3.4 rebounds in 27.3 minutes per night last season for the Wizards, posting a shooting line of .480/.382/.831 in 62 games (61 starts).

The Pistons’ press release did include a couple health updates that are more positive. Jalen Duren (right ankle) is expected to return to practice this week, according to the team, while Bojan Bogdanovic (right calf strain) has begun a return-to-play progression and has been cleared for full contact. Duren has missed the past five games, while Bogdanovic has yet to play this season.